UK markets closed

Ekso Bionics Holdings Inc (23E2.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
1.1250-0.0050 (-0.44%)
At close: 08:04AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
17,913
18,279
12,912
11,246
8,882
Cost of revenue
8,883
9,200
6,698
4,497
3,812
Gross profit
9,030
9,079
6,214
6,749
5,070
Operating expenses
Research development
5,007
5,025
3,626
2,549
2,474
Selling general and administrative
17,943
19,166
18,144
18,028
15,454
Total operating expenses
22,950
24,191
21,770
20,577
17,928
Operating income or loss
-13,920
-15,112
-15,556
-13,828
-12,858
Interest expense
247
302
156
113
139
Total other income/expenses net
-71
216
632
4,177
-2,828
Income before tax
-14,238
-15,198
-15,080
-9,764
-15,825
Income from continuing operations
-14,238
-15,198
-15,080
-9,764
-15,825
Net income
-14,238
-15,198
-15,080
-9,764
-15,825
Net income available to common shareholders
-14,238
-15,198
-15,080
-9,764
-15,825
Basic EPS
-1.12
-1.10
-1.16
-0.80
-2.21
Diluted EPS
-1.12
-1.10
-1.16
-0.88
-2.21
Basic average shares
13,544
13,867
12,962
12,193
7,164
Diluted average shares
13,544
13,867
12,962
12,269
7,164